Legal & General Group’s Neuropace NPCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $29.8K | Buy |
2,679
+1,239
| +86% | +$13.8K | ﹤0.01% | 2851 |
|
|
2025
Q1 | $17.7K | Sell |
1,440
-68
| -5% | -$836 | ﹤0.01% | 2983 |
|
|
2024
Q4 | $16.9K | Hold |
1,508
| – | – | ﹤0.01% | 3089 |
|
|
2024
Q3 | $10.5K | Hold |
1,508
| – | – | ﹤0.01% | 3262 |
|
|
2024
Q2 | $11.4K | Buy |
+1,508
| New | +$11.4K | ﹤0.01% | 3269 |
|
|
2022
Q2 | – | Sell |
-730
| Closed | -$6K | – | 3612 |
|
|
2022
Q1 | $6K | Hold |
730
| – | – | ﹤0.01% | 3490 |
|
|
2021
Q4 | $7K | Hold |
730
| – | – | ﹤0.01% | 3519 |
|
|
2021
Q3 | $12K | Hold |
730
| – | – | ﹤0.01% | 3417 |
|
|
2021
Q2 | $17K | Buy |
+730
| New | +$17K | ﹤0.01% | 3349 |
|